Agarose Resin Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Agarose resin is a naturally derived polysaccharide medium used primarily in liquid chromatography and electrophoresis for the separation and purification of biological macromolecules such as proteins, nucleic acids, and antibodies. The global market reached approximately $1.42 billion in 2025, with a wide range of industry estimates placing values between $680 million and $1.89 billion depending on scope, reflecting differences in whether the data covers agarose specifically or the broader agar resin market. Key applications span biopharmaceutical downstream processing, academic and clinical research laboratories, and diagnostic testing, with the pharmaceutical sector representing the largest end-use segment.

The market is being driven by the unprecedented expansion of biopharmaceutical production, particularly the manufacturing of monoclonal antibodies, vaccines, and cell and gene therapies that rely heavily on chromatography-based purification methods. Growing investment in molecular biology research, increasing prevalence of chronic diseases requiring biologic treatments, and the rising adoption of high-throughput laboratory workflows are all contributing to sustained demand. Additionally, the trend toward outsourcing bioprocessing to contract development and manufacturing organizations has increased aggregate consumption of chromatography resins globally.

The market is broadly segmented by product type, including agarose, sepharose, and cross-linked agarose variants, as well as by application such as gel filtration, ion exchange, affinity, and hydrophobic interaction chromatography. Geographically, North America holds the largest market share, driven by a high concentration of biotechnology and pharmaceutical companies, substantial research and development spending, and a well-established regulatory framework. The Asia-Pacific region is the fastest-growing market, fueled by increasing biopharmaceutical manufacturing capacity in countries such as China, India, and South Korea, along with rising life sciences research investment.

What are the recent trends and outlook?

Several key trends are shaping the future trajectory of the agarose resin market, including the development of high-flow, high-capacity resins optimized for continuous bioprocessing and single-use manufacturing systems. There is a growing emphasis on resin reuse and lifetime extension to reduce bioproduction costs, alongside demand for resins compatible with advanced purification platforms such as multimodal chromatography. The ongoing expansion of cell therapy and gene therapy manufacturing

Named companies and quantified developments shaping the Agarose Resin Market market.

• •Cytiva - In early 2024, Cytiva announced upgrades to its Sepharose agarose resin portfolio to improve throughput in monoclonal antibody purification.
• •Global Agarose Resin Market - The global Agarose Resin market size was valued at US$ 370 million in 2024 and is forecast to reach USD 600 million by 2031.